Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
April 16, 2019Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular conditions, today announced the appointment of Paul Edick as Chairman of its Board of Directors.
More »
Milestone Pharmaceuticals Appoints Michael Tomsicek to Board of Directors
April 4, 2019Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing acute therapies for the treatment of episodic cardiovascular indications, today announced the appointment of Michael Tomsicek to its Board of Directors.
More »
Iterum Therapeutics Receives QIDP for Oral and IV Sulopenem in Four Additional Indications as well as Fast Track Designation
March 19, 2019New designations in community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory disease demonstrate the clinical potential of sulopenem.
More »